Active
    SME

    Accretion Pharmaceuticals Ltd

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    Accretion Pharmaceuticals Ltd IPO opened on 14 May 2025 and closed on 16 May 2025, with a price band of ₹96–₹101 per share. The IPO had a lot size of 600 shares, requiring a minimum investment of ₹1,21,200 per lot at the upper price band. The issue size was ₹29.75 crore, and the shares get listed on 21 May 2025.

    Accretion Pharmaceuticals Ltd IPO Details

    Listing Date

    21 May 2025

    Bid Price

    ₹96 - ₹101

    Lot Size

    600 Shares

    Minimum Investment

    ₹1,21,200 / 2 Lots

    Issue Size

    ₹29.75 Cr

    Key Dates to Track

        Here are the important dates you need to know in order to participate in this IPO

    tick

    Offer Start Date

    14th May

    tick

    Offer End Date

    16th May

    tick

    Allotment Date

    19th May

    tick

    Refund Initiation

    20th May

    tick

    Demat Transfer

    20th May

    tick

    Listing Date

    21st May

    About Accretion Pharmaceuticals Ltd IPO

    Accretion Pharmaceuticals Limited, incorporated in 2012, is a growing pharmaceutical company primarily engaged in the manufacturing and marketing of a wide range of healthcare products. Its offerings include tablets, capsules, oral liquids, and various external preparations such as ointments, creams, gels, lotions, medicated shampoos, mouthwash, and dusting powders, as well as oral powders like sachets and dry syrups. The company caters to both direct sales and contract manufacturing clients, operating majorly on a principal-to-principal business model. With ISO 9001:2015, ISO 14001:2015, and ISO 22000:2018 certifications, Accretion Pharmaceuticals demonstrates a strong commitment to quality and regulatory compliance.
     

    The company’s state-of-the-art manufacturing unit is situated in Sanand, Ahmedabad, Gujarat. Accretion Pharmaceuticals has established a robust presence in the domestic market while also extending its footprint globally, serving clients in over 20 countries across Africa, Southeast Asia, and the Middle East. Backed by an experienced board and a skilled management team, the company continues to focus on innovation, strategic partnerships, and regulatory excellence, positioning itself as a reliable player in the pharmaceutical manufacturing space.

    Accretion Pharmaceuticals Ltd Shareholding Pattern

      Pre-Issue Post-Issue
    Promoter Group 100% 73.14%
    Public Group 0% 26.86%

    Accretion Pharmaceuticals Ltd IPO Reservation

    QIB Shares Offered 3,52,800 (11.98%)
    NII (HNI) Shares Offered 12,22,800 (41.51%)
    Retail Shares Offered 12,22,800 (41.51%)
    Anchor Investor Shares Offered 0 (0%)
    Total Shares Offered 29,46,000
    Total Shares With Anchor Investor 29,46,000

    Accretion Pharmaceuticals Ltd IPO Lot Size

    Application Lots Shares Amount
    Retail (Min) 2 1,200 ₹1,21,200
    Retail (Max) 2 1,200 ₹1,21,200
    S HNI (Min) 3 1,800 ₹1,81,800
    S HNI (Max) 16 9,600 ₹9,69,600
    B HNI (MIN) 17 10,200 ₹10,30,200

    Accretion Pharmaceuticals Ltd IPO Anchor Portion Size

    Shares Offered 2,11,200
    Anchor Investment Details 2.13312

    Accretion Pharmaceuticals Ltd IPO registrar

    KFin Techologies Ltd
    Phone Number +91-40-6716 2222/
    Email Id apl.ipo@kfintech.com
    Website www.kfintech.com

    Accretion Pharmaceuticals Ltd IPO Lead Manager

    1. Jawa Capital Services Pvt Ltd

    Accretion Pharmaceuticals Ltd Financial Information

    March 31, 2025 March 31, 2024 March 31,
    Net Worth ₹15.29 Cr ₹5.49 Cr ₹ Cr
    Reserves and Surplus ₹7.12 Cr ₹1.49 Cr ₹ Cr
    Total Borrowing ₹14.1 Cr ₹13.48 Cr ₹ Cr

    Accretion Pharmaceuticals Ltd IPO Subscription LIVE Status

    Category No. of shares offered No. of shares bid Subscription (Times)
    Qualified Institutional Buyers (QIBs) 3,52,800 17,19,600 4.8742
    Non Institutional Investors (NIIs) 12,22,800 53,91,600 4.4092
    Retail Individual Investors (RIIs) 12,22,800 1,28,95,200 10.5456
    Total 27,34,800 2,00,06,400 7.3155

    Strength of Accretion Pharmaceuticals Ltd

    • Experienced Promoters and Management Team.
    • Consistently supplying quality products to our valued customers in time.
    • Continually improving the quality standards by implementing process control and prevention techniques.
    • Long-standing relationship with clients and suppliers.
    • Quality standards.
    • Legacy Business Process & Management.
    • Strong and experienced R&D team.

    Risks Involved

    • A significant portion of its revenue is derived from exports, and any decline in export profitability may adversely impact its overall financial performance.
    • The Company operates in pharmaceutical sector, which is extensively regulated, any failures on the company part to comply with the existing and future statutory and/or regulatory requirements in the pharmaceutical sector could adversely affect its business, results of operations and financial condition.
    • Its manufacturing units are subject to periodic inspections and audits by regulatory authorities and clients. Its may be subject to regulatory action which may damage the company reputation leading to an adverse effect on its business, results of operations, financial condition and cash flows.
    • The company has a very limited operating history as a Company, which may make it difficult for investors to evaluate its historical performance or future prospects.
    • The company has only one Manufacturing Facility, continued operations of its manufacturing facility is critical to the company business and any disruption in the operation of its manufacturing facility may have a material adverse effect on the company business, results of operations and financial condition.
    • The company generate a significant percentage of its revenue from few clients. The loss of any one or more of the company major clients would have a material adverse effect on its business operations and profitability.
    • Its inability to accurately forecast demand for the company products or manage its inventory or working capital requirements may have an adverse effect on the company business, results of operations and financial condition.
    • There was a Criminal litigation against its promoters cum directors and the company is not sure the same shall not be refiled by the concerned authority. In the event it is refiled, the interest of the promoters may divert from the business of the Company, which may adversely affect the business of the Company.
    • Its business operations are working capital intensive, and any inability to meet the company working capital requirements may adversely impact its financial condition and growth prospects.
    • The company has certain outstanding litigation against it, an adverse outcome of which may adversely affect its business, reputation and results of operations.
    stock
    Invest in IPOs with ease

    Sign-in to invest with your demat account, or set up a new demat account for free

    Industry Outlook of Accretion Pharmaceuticals IPO

    • India holds a significant position in the global pharmaceuticals sector.

    • Key segments include: generic medicines, OTC drugs, bulk drugs, vaccines, biosimilars, biologics, and contract research & manufacturing.

    • India is a global leader in vaccine production, particularly for DPT, BCG, and Measles vaccines.

    • The country is the world’s largest supplier of generic medicines, contributing 20% of global volume.

    • It also leads globally in vaccine manufacturing.

    • India hosts the highest number of US-FDA approved pharmaceutical plants outside the US.

    • The nation is home to over 3,000 pharmaceutical companies and has more than 10,500 manufacturing units.

    • It benefits from a vast pool of highly skilled professionals.

    • The Indian pharmaceutical industry is currently valued at $50 billion.

    • It is projected to grow to $65 billion by 2024 and $130 billion by 2030.


    Interested in more opportunities? Check out our Upcoming IPO section for new listings and don’t forget to check your IPO allotment status for Accretion Pharmaceuticals IPO.

    Explore Other IPOs

    • Current IPOs
    • Upcoming IPOs
    • Closed IPOs
    • IPO Performance
    • All
    • MainBoard
    • SME
    SILVERSTORM PARKS AND RESORTS LIMITED IPO
    icon
    Closing Tomorrow
    SME IPO
    Early Access
    Bidding Period
    24th Jul 2026 - 7th Jul 2026
    Price Range
    ₹123.0 - 133.0
    IPO Size
    ₹82,43,00,032
    ADVANCE TECHNOFORGE LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    27th Jul 2026 - 7th Jul 2026
    Price Range
    ₹95.0 - 95.0
    IPO Size
    ₹24,03,00,000
    Bidding Period
    27th Jul 2026 - 7th Jul 2026
    Price Range
    ₹65.0 - 69.0
    IPO Size
    ₹28,57,00,000
    Bidding Period
    28th Jul 2026 - 7th Jul 2026
    Price Range
    ₹285.0 - 301.0
    IPO Size
    ₹1,59,83,00,032
    • All
    • MainBoard
    • SME
    H R Hygiene Products Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    29th Jul 2026 - 7th Jul 2026
    Price Range
    ₹83.0 - 88.0
    IPO Size
    ₹53,95,00,032
    Bidding Period
    29th Jul 2026 - 7th Jul 2026
    Price Range
    ₹560.0 - 590.0
    IPO Size
    ₹92,75,21,99,680
    Dhaval Packaging Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    30th Jul 2026 - 8th Aug 2026
    Price Range
    ₹92.0 - 97.0
    IPO Size
    ₹36,36,00,000
    Juniper Green Energy Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    30th Jul 2026 - 8th Aug 2026
    Price Range
    ₹214.0 - 225.0
    IPO Size
    ₹17,99,99,98,976
    MV Electrosystems Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    30th Jul 2026 - 8th Aug 2026
    Price Range
    ₹400.0 - 425.0
    IPO Size
    ₹0
    Bidding Period
    30th Jul 2026 - 8th Aug 2026
    Price Range
    ₹91.0 - 96.0
    IPO Size
    ₹0
    Bidding Period
    31st Jul 2026 - 8th Aug 2026
    Price Range
    ₹151.0 - 159.0
    IPO Size
    ₹39,04,00,000
    G V Electricals Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    31st Jul 2026 - 8th Aug 2026
    Price Range
    ₹123.0 - 130.0
    IPO Size
    ₹0
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    AceVector Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Advanced SysTek Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Advanta Enterprises Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Agilus Diagnostics Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Airox Technologies Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Ajay Poly Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Allchem Lifescience Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    NO ACTIVE IPO HERE
    • All
    • MainBoard
    • SME
    INDOMIM LIMITED IPO
    icon
    Closing Today
    SME IPO
    Early Access
    Bidding Period
    23rd Jul 2026 - 7th Jul 2026
    Price Range
    ₹461.0 - 485.0
    IPO Size
    ₹38,12,10,99,264
    LOHIA CORP LIMITED IPO
    icon
    Closing Today
    SME IPO
    Early Access
    Bidding Period
    23rd Jul 2026 - 7th Jul 2026
    Price Range
    ₹404.0 - 425.0
    IPO Size
    ₹11,02,08,00,000
    XTRANET TECHNOLOGIES LIMITED IPO
    icon
    Closing Today
    SME IPO
    Early Access
    Bidding Period
    23rd Jul 2026 - 7th Jul 2026
    Price Range
    ₹120.0 - 127.0
    IPO Size
    ₹1,66,80,00,000
    CUBE HIGHWAYS TRUST IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    22nd Jul 2026 - 7th Jul 2026
    Price Range
    ₹151.0 - 152.0
    IPO Size
    ₹49,99,99,98,976
    Bidding Period
    22nd Jul 2026 - 7th Jul 2026
    Price Range
    ₹66.0 - 70.0
    IPO Size
    ₹18,90,00,000
    METALIC TECHNOFORGE LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    21st Jul 2026 - 7th Jul 2026
    Price Range
    ₹72.0 - 77.0
    IPO Size
    ₹49,96,00,000
    GULF LLOYDS INDIA LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    20th Jul 2026 - 7th Jul 2026
    Price Range
    ₹100.0 - 100.0
    IPO Size
    ₹18,19,00,000
    Bidding Period
    17th Jul 2026 - 7th Jul 2026
    Price Range
    ₹402.0 - 424.0
    IPO Size
    ₹4,49,99,99,744
    SOTEFIN BHARAT LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    16th Jul 2026 - 7th Jul 2026
    Price Range
    ₹178.0 - 187.0
    IPO Size
    ₹89,76,00,000
    ALPINE TEXWORLD LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    14th Jul 2026 - 7th Jul 2026
    Price Range
    ₹100.0 - 105.0
    IPO Size
    ₹1,26,24,99,968
    Bidding Period
    14th Jul 2026 - 7th Jul 2026
    Price Range
    ₹315.0 - 331.0
    IPO Size
    ₹1,60,33,99,936
    SBI FUNDS MANAGEMENT LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    14th Jul 2026 - 7th Jul 2026
    Price Range
    ₹545.0 - 574.0
    IPO Size
    ₹97,95,32,02,176
    Bidding Period
    9th Jul 2026 - 7th Jul 2026
    Price Range
    ₹203.0 - 214.0
    IPO Size
    ₹7,42,00,00,256
    HAPPY STEELS LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    9th Jul 2026 - 7th Jul 2026
    Price Range
    ₹62.0 - 66.0
    IPO Size
    ₹25,08,00,000
    DEVSON CATALYST LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    9th Jul 2026 - 7th Jul 2026
    Price Range
    ₹112.0 - 118.0
    IPO Size
    ₹42,34,00,000
    KUSUMGAR LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    8th Jul 2026 - 7th Jul 2026
    Price Range
    ₹398.0 - 419.0
    IPO Size
    ₹6,49,99,99,744
    Bidding Period
    3rd Jul 2026 - 7th Jul 2026
    Price Range
    ₹94.0 - 99.0
    IPO Size
    ₹47,91,00,000
    KNACK PACKAGING LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    1st Jul 2026 - 7th Jul 2026
    Price Range
    ₹161.0 - 170.0
    IPO Size
    ₹4,39,49,99,808
    KRATIKAL TECH LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    30th Jun 2026 - 7th Jul 2026
    Price Range
    ₹128.0 - 135.0
    IPO Size
    ₹39,69,00,000
    SEEMAX RESOURCES LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    30th Jun 2026 - 7th Jul 2026
    Price Range
    ₹134.0 - 141.0
    IPO Size
    ₹19,74,00,000
    • All
    • MainBoard
    • SME
    Issue Prize
    424.00
    Listing Day Close
    528.50(24.76%)
    SOTEFIN BHARAT LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    187.00
    Listing Day Close
    215.25(14.97%)
    ALPINE TEXWORLD LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    105.00
    Listing Day Close
    99.75(-4.76%)
    Issue Prize
    331.00
    Listing Day Close
    660.30(99.40%)
    SBI FUNDS MANAGEMENT LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    574.00
    Listing Day Close
    609.90(6.27%)
    Issue Prize
    214.00
    Listing Day Close
    262.85(22.90%)
    HAPPY STEELS LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    66.00
    Listing Day Close
    68.50(4.55%)
    DEVSON CATALYST LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    118.00
    Listing Day Close
    205.95(74.58%)
    KUSUMGAR LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    419.00
    Listing Day Close
    604.45(44.15%)
    Issue Prize
    99.00
    Listing Day Close
    174.30(75.76%)
    KNACK PACKAGING LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    170.00
    Listing Day Close
    182.70(7.65%)
    KRATIKAL TECH LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    135.00
    Listing Day Close
    182.40(34.81%)
    SEEMAX RESOURCES LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    141.00
    Listing Day Close
    107.20(-24.11%)
    Issue Prize
    84.00
    Listing Day Close
    93.45(10.71%)
    ATHARVA POLYPLAST LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    60.00
    Listing Day Close
    72.45(20.00%)
    Issue Prize
    220.00
    Listing Day Close
    438.90(99.55%)
    VINIT MOBILE LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    158.00
    Listing Day Close
    147.25(-6.96%)
    Issue Prize
    70.00
    Listing Day Close
    82.16(17.14%)
    AASTHA SPINTEX LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    136.00
    Listing Day Close
    136.45(0.00%)
    Issue Prize
    99.00
    Listing Day Close
    174.30(75.76%)

    Frequently Asked Questions

    What is Accretion Pharmaceuticals Ltd IPO?

    Answer Field

    Accretion Pharmaceuticals Ltd IPO is a SME IPO of 29,46,000 equity shares of a face value of ₹10 aggregating up to ₹29.75 Crores. The issue is priced at ₹96 to ₹101 per share. The minimum order quantity is 600 Shares. The IPO opens on May 14, 2025, and closes on May 16, 2025. KFin Techologies Ltd is the registrar for the IPO. The shares are proposed to be listed on NSE-SME.

    When Accretion Pharmaceuticals Ltd IPO will open?

    Answer Field

    The Accretion Pharmaceuticals Ltd IPO opens on May 14, 2025 and closes on May 16, 2025.

    What is the lot size of Accretion Pharmaceuticals Ltd?

    Answer Field

    Accretion Pharmaceuticals Ltd lot size is 600 shares, and the minimum amount required is ₹1,21,200.

    How to apply for Accretion Pharmaceuticals Ltd IPO?

    Answer Field

    You can apply in Accretion Pharmaceuticals Ltd IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. To apply for an IPO:

    • Login to Bajaj Broking account App/Website & click on IPO
    • Enter the number of lots and price at which you wish to apply.
    • Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.
    • You will receive a mandate notification to block funds in your UPI app.
    • Approve the mandate request on your UPI and funds will be blocked.

    When is Accretion Pharmaceuticals Ltd IPO allotment?

    Answer Field

    The finalization of Basis of Allotment for Accretion Pharmaceuticals Ltd IPO will be done on May 19, 2025, and the allotted shares will be credited to your demat account by May 20, 2025.

    When is Accretion Pharmaceuticals Ltd IPO listing date?

    Answer Field

    The Accretion Pharmaceuticals Ltd listing date is May 21, 2025.

    Who is the registrar of Accretion Pharmaceuticals Ltd IPO?

    Answer Field

    The registrar of Accretion Pharmaceuticals Ltd IPO is KFin Techologies Ltd

    Which company is the book-running lead manager of the IPO?

    Answer Field

    Jawa Capital Services Pvt Ltd will be the book-running lead manager of this IPO.

    What is the fresh issue of Accretion Pharmaceuticals Ltd IPO?

    Answer Field

    The fresh issue size is ₹29.75 Crores equity shares.

    What minimum lot size can retail subscribers subscribe to Accretion Pharmaceuticals Ltd?

    Answer Field

    Retail investors can subscribe to a minimum of one lot, 600 shares and ₹1,21,200 amount.

    How can I approve the UPI mandate request for Accretion Pharmaceuticals Ltd IPO?

    Answer Field

    To apply for Accretion Pharmaceuticals Ltd IPO, you need to log in to your demat account to complete the bidding process. Then, approve the payment mandate on your UPI app.

    What is the price range of Accretion Pharmaceuticals Ltd?

    Answer Field

    The price of each Accretion Pharmaceuticals Ltd share will be ranging in between ₹96 to ₹101 per share.

    What is the cut-off time for the UPI mandate for Accretion Pharmaceuticals Ltd IPO?

    Answer Field

    The cut-off time for the UPI mandate confirmation is 5:00 PM, May 16, 2025.

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |